Don Farthing

37 papers receiving 1.2k citations

Hit Papers

Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis 2014 · 384 citations
3842014202620182022100200300

Peers

Don Farthing
Comparison fields: 5 of 118
  • Critical Care and Intensive Care Medicine 127
  • Analytical Chemistry 235
  • Nutrition and Dietetics 328
  • Bioengineering 89
  • Pharmacology 188
Replace Christine Farthing with:
Christine Farthing United States
Min Jung Chang South Korea
George F. Johnson United States
Danuta Siluk Poland
Sihe Wang United States
Oliver Yoa‐Pu Hu Taiwan
Pascale Macours Belgium
Julie Ducharme Canada
Günter Fauler Austria
Don Farthing relative to Christine Farthing United States Christine Farthing's profile →
Citations per field
00.5×6.7×
Christine Farthing · 1×
Citations per year

Countries citing papers authored by Don Farthing

Since Specialization
Citations

This map shows the geographic impact of Don Farthing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don Farthing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don Farthing more than expected).

Fields of papers citing papers by Don Farthing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don Farthing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don Farthing. The network helps show where Don Farthing may publish in the future.

Co-authors

The 25 scholars most cited alongside Don Farthing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Don Farthing Line = papers co-authored together Don Farthing links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
Hit paper breakdown →
2014384
2 2014104
3 201580
4 199756
5 200756
6 201053
7 199847
8 200536
9 199934
10 199728
11 199427
12 202125
13 199025
14
Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma
199724
15 198723
16 200823
17 200422
18 199221
19 199421
20 200919

About Don Farthing

Don Farthing is a scholar working on Analytical Chemistry, Bioengineering, Pharmacology, Spectroscopy and Pharmaceutical Science, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (11 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Analytical Chemistry and Chromatography (6 papers), Cardiac electrophysiology and arrhythmias (4 papers), Analytical Chemistry and Sensors (4 papers), Cardiac Imaging and Diagnostics (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Metabolism and Genetic Disorders (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (127 citations), Analytical Chemistry (235 citations), Nutrition and Dietetics (328 citations), Bioengineering (89 citations) and Pharmacology (188 citations). Don Farthing has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Christine Farthing, Itaf Fakhry, Domenic Sica, Terri Larus, Todd W.B. Gehr, Lei Xi, Donald F. Brophy, Robin Sculthorpe, Bernard Fisher and Shelley Knowlson. Their work appears in journals such as Journal of Chromatography B, Biomarkers, Journal of Pharmaceutical Sciences, Scientific Reports and Biomedical Chromatography.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026